Justin J. McAnear, Chief Financial Officer at 10x Genomics, Inc. (TXG), sold 14,500 shares at $193.40 ($2.8M) on 2021-05-03, disclosed to the SEC on 2021-05-05.
Open-market sale of $2.8M TXG by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $189.57 | 600 | $114K | 4.1% |
| 2 | $190.63 | 1,900 | $362K | 13.0% |
| 3 | $191.77 | 2,700 | $518K | 18.6% |
| 4 | $192.46 | 3,706 | $713K | 25.6% |
| 5 | $192.46 | 3,706 | $713K | 25.6% |
| 6 | $193.40 | 794 |
| $154K |
| 5.5% |
| 7 | $193.40 | 794 | $154K | 5.5% |
| 8 | $194.92 | 200 | $39K | 1.4% |
| 9 | $198.09 | 100 | $20K | 0.7% |
| Total | $192.15 avg | 14,500 | $2.8M | 100% |
| Filing → |
| TXG | SELL | 2024-02-26 | $173K | — | Filing → |
| TXG | SELL | 2023-11-27 | $146K | — | Filing → |
| TXG | SELL | 2023-08-24 | $154K | — | Filing → |